Search results
Results from the WOW.Com Content Network
UPPP involves removal of the tonsils, the posterior surface of the soft palate, and the uvula. The uvula is then folded toward the soft palate and sutured together as demonstrated in the figures. In the US, UPPP is the most commonly performed procedure for obstructive sleep apnea with approximately 33,000 procedures performed per year.
During the late 1990s and the 2000s, researchers (including Finkelstein, [4] Schmidt, Larrosa [5] and others) published data which questioned the efficiency of the treatment and demonstrated that in a considerable number of cases, laser-assisted uvulopalatoplasty may also cause mild obstructive sleep apnea in patients who has been nonapneic ...
For those with obstructive sleep apnea unable or unwilling to comply with first line treatment, the surgical intervention has to be adapted to an individual's specific anatomy and physiology, personal preference and disease severity. [114] Uvulopalatopharyngoplasty with or without is the most common surgery for patients with obstructive sleep ...
The AIO Breathe Device is a “new mandibular repositioning device” that was designed by local sleep physician Dr. Raghavendra V. Ghuge, MD, MBA, DABSM, […] FDA clears Tyler company’s device ...
Hyoid suspension, also known as hyoid myotomy and suspension or hyoid advancement, is a surgical procedure or sleep surgery in which the hyoid bone and its muscle attachments to the tongue and airway are pulled forward with the aim of increasing airway size and improving airway stability in the retrolingual and hypopharyngeal airway (airway behind and below the base of tongue).
Obstructive sleep apnea or sleep apnea is defined as either cessation of breathing (apnea) for 10 seconds, or a decrease in normal breathing (hypopnea) with an associated desaturation in oxygen and arousal during sleep that lasts at least 10 seconds. In adults, it is typical to have up to 4.9 events per hour.
Somnoplasty [1] is a trademark by Somnus Medical Technologies [2] used for its radiofrequency ablation medical devices cleared by the Food and Drug Administration (FDA) to treat habitual snoring, chronic nasal obstruction, and obstructive sleep apnea (OSA) to shrink the tissues that are causing obstruction.
Central sleep apnea due to a drug or substance 327.29 F10-19 Primary sleep apnea of infancy 770.81 P28.3 Obstructive sleep apnea syndromes: Obstructive sleep apnea, adult 327.23 G47.33 Obstructive sleep apnea, pediatric 327.23 G47.33 Sleep-related hypoventilation/hypoxemic syndromes: Sleep-related non-obstructive alveolar hypoventilation ...